Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study

20233 citationsJournal Articlegold Open Access

Authors

Yasunori Murata · Ichinomiya Kenshin College

Shigeru Tanzawa · Teikyo University

Toshihiro Misumi · National Cancer Center Hospital East

Hiroshige Yoshioka · Kansai Medical University

Eisaku Miyauchi · Tohoku University Hospital

Kiichiro Ninomiya · Novartis (Switzerland)

Masafumi Takeshita

Abstract

GCN for ICI-pretreated patients with LSqCC seems tolerable and offers promising efficacy regardless of treatment line, and ICI pretreatment might enhance GCN efficacy.

Topics & Keywords

Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Colorectal and Anal Carcinomas

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JTO Clinical and Research Reports

Volume 4, Issue 12, pp. 100593-100593

DOI: 10.1016/j.jtocrr.2023.100593

Field-Weighted Citation Impact: 0.78